Anita Blanka Tryc

Anita Blanka Tryc

Auto-generated profile, based on publicly available information

Anita Blanka Tryc

Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30623, Hannover, Germany.

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
HWHans Worthmann
Hans Worthmann
ATAnita B Tryc
Anita B Tryc
MDMeike Dirks
Meike Dirks
RSRamona Schuppner
Ramona Schuppner
KBKorbinian Brand
Korbinian Brand
KWKarin Weissenborn
Karin Weissenborn
Ischemic stroke patients are prone to infection by stroke-induced immunodepression. We hypothesized that levels of lipopolysaccharide binding protein (LBP), interleukin-10 (IL-10), IL-6 and C-reactive protein (CRP) are early predictors for the development of stroke-associated infection. Fifty-six patients with ischemic stroke (n = 51) and transient ischemic attack (TIA) (n = 5) who presented within 6 hours after symptom onset and who were free of detectable infection on admission were included in the study. Of these, 20 developed early infections during the first week. Blood samples were taken at 6, 12, and 24 hours and at 3 and 7 days after stroke onset. Levels of LBP, Il-10, IL-6 and CRP, as well as S100B, were measured as markers of inflammation and brain damage by commercially available immunometric tests. In the univariate analysis, levels of LBP, IL-10, IL-6 and CRP significantly differed between patients who developed an infection and those who did not. In the binary logistic regression analysis, which was adjusted for National Institutes of Health Stroke Scale (NIHSS) on admission, stroke subtype and S100B peak levels, as indicator of the extent of brain damage, IL-10 at 6 hours, CRP at 6 hours and NIHSS on admission were identified as independent predictors of infection (IL-10: P = 0.009; CRP: P = 0.018; NIHSS: P = 0.041). The area under the curve (AUC) of the receiver operating characteristic (ROC) curves in relation to the dichotomized status of the infection (infection versus no infection) was 0.74 (95% confidence interval: 0.59 to 0.88) for CRP at 6 hours, 0.76 (0.61 to 0.9) for IL-10 at 6 hours, 0.83 (0.71 to 0.94) for NIHSS on admission and 0.94 (0.88 to 1) for the combination of CRP, IL-10 and NIHSS. In a subanalysis, 16 patients with early infections were matched with 16 patients without infection according to S100B peak levels. Here, the temporal pattern of LBP, IL-10, IL-6 and CRP significantly differed between the patient groups. Our data show that blood levels of inflammation markers may be used as early predictors of stroke-associated infection. We propose prospective studies to investigate if the calculated cut-offs of CRP, IL-10 and NIHSS might help to identify patients who should receive early preventive antibiotic treatment.

7 January 2011 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
ATAnita Blanka Tryc
Anita Blanka Tryc
GAGüldan Alwan
Güldan Alwan
MBMartin Bokemeyer
Martin Bokemeyer
AGAnnemarie Goldbecker
Annemarie Goldbecker
HHHartmut Hecker
Hartmut Hecker
KWKarin Weissenborn
Karin Weissenborn
Background. The diagnosis of uraemic encephalopathy is considered if patients with end-stage renal disease present with neuropsychiatric symptoms. However, cognitive deficits may occur in patients with chronic kidney disease (CKD) long before any overt neurological symptoms can be observed. We hypothesized that cognitive dysfunction in patients with CKD both, treated and untreated by haemodialysis, may correspond to metabolic changes in distinct brain regions. Methods. We performed magnetic resonance spectroscopy (MRS) ( 1 H-MRS) of the brain in 23 non-dialysed patients with CKD (Stages 4–5) and in 15 haemodialysed patients. Healthy controls ( n = 63) adjusted for age and education were recruited from the social environment of the patients' population. Attention, learning and memory were assessed by psychometric testing. Results. MRS alterations were predominantly found in the white matter. Concentrations of creatine-containing compounds (Cr) were decreased in dialysed and non-dialysed patients. Choline concentration (Cho) and combined N -acetylaspartate and N -acetylaspartylglutamate concentration (NAx) were reduced only in dialysed patients. Disturbance in memory and learning ability as well as attention deficits were observed in both patient groups. Of note, attention deficits were more severe in dialysed patients. MRS results correlated with attention deficits in dialysed patients. Conclusions. CKD patients without clinical signs of uraemic encephalopathy showed metabolic disturbances in distinct brain regions as well as cognitive impairments. Haemodialysis was accompanied with more severe cognitive dysfunction and metabolic alternations than CKD alone. Although the small sample size limits the interpretation of the data, a negative impact of haemodialysis on cognitive function must be considered.

4 November 2014 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
MBMartina Bernhardt
Martina Bernhardt
HPHenning Pflugrad
Henning Pflugrad
AGAnnemarie Goldbecker
Annemarie Goldbecker
HBHannelore Barg‐Hock
Hannelore Barg‐Hock
WKWolfgang Knitsch
Wolfgang Knitsch
ATAnita Blanka Tryc
Anita Blanka Tryc
Although central nervous system complications (CNSCs) are common after orthotopic liver transplantation (OLT), standardized prospective studies are still lacking. This prospective study was aimed at determining the incidence of CNSCs, describing their clinical presentations, and establishing predicting factors. One hundred thirty‐six adult patients who underwent OLT at Hannover Medical School between December 2008 and June 2011 were included. Weekly examinations were performed by a neurologist during the hospital stay after OLT. Patient data, donor data, and operative and postoperative variables were collected. Patients with cerebral dysfunction after OLT underwent a diagnostic work‐up, which included brain imaging and, if necessary, cerebrospinal fluid analysis. Patients with central nervous system (CNS) symptoms but negative imaging and cerebrospinal fluid results and patients with pontine myelinolysis or posterior reversible encephalopathy syndrome were placed in a metabolic‐toxic CNSC group, and patients with strokes, intracranial hemorrhaging, or CNS infections were placed in a nonmetabolic CNSC group. Multiple regression analysis was used to identify independent risk factors for the development of metabolic‐toxic CNSCs. After excluding two patients that died after OLT without regaining consciousness, forty‐four (32.8%) patients developed CNSCs: 37 of these patients (27.6%) had metabolic‐toxic CNSCs, and 7 (5.2%) had nonmetabolic CNSCs. Acute‐on‐chronic liver failure, the number of subsequent surgeries, and primary sclerosing cholangitis were identified as independent predictors for the development of metabolic‐toxic CNSCs. Metabolic‐toxic CNSCs were associated with prolonged hospital stays, and nonmetabolic CNSCs were associated with higher mortality. In conclusion, CNSCs are common and relevant complications after OLT. Patients after OLT, especially with risk factors, should undergo a regular standardized neurological examination that would allow early detection of these complications. Liver Transpl 21:224‐232, 2015. © 2014 AASLD.

8 April 2014 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
ATAnita Blanka Tryc
Anita Blanka Tryc
HPHenning Pflugrad
Henning Pflugrad
AGAnnemarie Goldbecker
Annemarie Goldbecker
HBHannelore Barg-Hock
Hannelore Barg-Hock
CSChristian P. Strassburg
Christian P. Strassburg
KWKarin Weissenborn
Karin Weissenborn
Patients after orthotopic liver transplantation (OLT) may show cognitive dysfunction. To date, it has not been clear whether this dysfunction is due to residual hepatic encephalopathy (HE) or new-onset cognitive disturbances. Just as little is known about the course and clinical significance. In this prospective, observational study, 50 patients on the waiting list for OLT were examined in an outpatient setting before OLT and 6 and 12 months after OLT with the Psychometric Hepatic Encephalopathy Score, the Inhibitory Control Test, and the critical flicker frequency for the diagnosis of HE; in addition, the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used as a tool for the measurement of global cognitive function. The Short Form 36 health survey was used to assess health-related quality of life. Twelve months after OLT, cognitive dysfunction characteristic of HE had resolved, but a secondary cognitive decline became apparent and had features different from those known with HE. Approximately 70% of the patients deteriorated in at least 1 cognitive domain of RBANS. This cognitive decline was related to neither a history of HE nor a history of alcohol abuse, but it was accompanied by a decline in the quality of life. In conclusion, OLT improves HE but is frequently followed by new-onset cognitive dysfunction, which can interfere with the quality of life. Liver Transpl 20:807–814, 2014. © 2014 AASLD.

17 November 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
SCShufen Chen
Shufen Chen
JMJens Martens-Lobenhoffer
Jens Martens-Lobenhoffer
KWKarin Weissenborn
Karin Weissenborn
JKJan T Kielstein
Jan T Kielstein
RLRalf Lichtinghagen
Ralf Lichtinghagen
HWHans Worthmann
Hans Worthmann
Elevated levels of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are accompanied by endothelial dysfunction and predict adverse outcome after ischemic stroke. Via induction of oxidative stress, dimethylarginines are possibly linked to the inflammatory cascade after stroke that is known to considerably contribute to secondary progression of brain injury. We sought to investigate the association between dimethylarginines and inflammatory mediators in patients with acute ischemic stroke.

10 April 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
GGGerrit M. Grosse
Gerrit M. Grosse
ATAnita B Tryc
Anita B Tryc
MDMeike Dirks
Meike Dirks
RSRamona Schuppner
Ramona Schuppner
HPHenning Pflugrad
Henning Pflugrad
HWHans Worthmann
Hans Worthmann
The chemokine fractalkine (CX3CL1, FKN) is involved in neural-microglial interactions and is regarded as neuroprotective according to several in vivo studies of inflammatory and degenerative states of the brain. Recently, an association with outcome in human ischemic stroke has been proposed. In this study, we aimed to investigate the temporal pattern of FKN levels in acute ischemic stroke in relation to stroke severity and outcome.